News
DNA
12.01
-2.91%
-0.36
Weekly Report: what happened at DNA last week (1102-1106)?
Weekly Report · 1d ago
Ginkgo Bioworks (DNA) Q3 2026 Earnings Call Transcript
The Motley Fool · 5d ago
Ginkgo Bioworks affirms 2026 cash burn target ($150M)-($125M)
TipRanks · 5d ago
Press Release: Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
Dow Jones · 5d ago
Ginkgo Bioworks' Data Partnership Strategy Could Either Validate the Model or Reveal Its Limits
Barchart · 6d ago
Weekly Report: what happened at DNA last week (1026-1030)?
Weekly Report · 11/02 09:29
Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
NASDAQ · 10/29 21:15
Ginkgo Bioworks Schedules Interactive Third-Quarter 2026 Update
TipRanks · 10/29 20:46
Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.
The Motley Fool · 10/29 08:42
Weekly Report: what happened at DNA last week (1019-1023)?
Weekly Report · 10/26 09:29
Did Ginkgo Bioworks Fall Catch You Out? What Investors Missed
Simply Wall St · 10/25 09:40
Ginkgo Bioworks Holdings Consensus Price Target Raised 14.29% to $8.16
NASDAQ · 10/23 09:58
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
NASDAQ · 10/20 21:15
Weekly Report: what happened at DNA last week (1012-1016)?
Weekly Report · 10/19 09:29
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
NASDAQ · 10/14 21:15
Ginkgo Bioworks Holdings Price Target Raised to $11.00/Share From $9.00 by TD Cowen
Dow Jones · 10/13 16:53
Ginkgo Bioworks Holdings Is Maintained at Hold by TD Cowen
Dow Jones · 10/13 16:53
TD Cowen Maintains Hold on Ginkgo Bioworks Holdings, Raises Price Target to $11
Benzinga · 10/13 16:43
Weekly Report: what happened at DNA last week (1005-1009)?
Weekly Report · 10/12 09:31
Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy
Benzinga · 10/09 16:49
More
Webull provides a variety of real-time DNA stock news. You can receive the latest news about Ginkgo Bioworks Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About DNA
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.